IE34882L - Pharmaceutical composition - Google Patents

Pharmaceutical composition

Info

Publication number
IE34882L
IE34882L IE701346A IE134670A IE34882L IE 34882 L IE34882 L IE 34882L IE 701346 A IE701346 A IE 701346A IE 134670 A IE134670 A IE 134670A IE 34882 L IE34882 L IE 34882L
Authority
IE
Ireland
Prior art keywords
pharmaceutical composition
pharmaceutical
composition
Prior art date
Application number
IE701346A
Other versions
IE34882B1 (en
Original Assignee
Smith Kline French Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smith Kline French Lab filed Critical Smith Kline French Lab
Priority to IE1342/75A priority Critical patent/IE35578B1/en
Priority to IE1341/75A priority patent/IE35577B1/en
Publication of IE34882L publication Critical patent/IE34882L/en
Publication of IE34882B1 publication Critical patent/IE34882B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/44—Iso-indoles; Hydrogenated iso-indoles
    • C07D209/48—Iso-indoles; Hydrogenated iso-indoles with oxygen atoms in positions 1 and 3, e.g. phthalimide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/24—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/26—Radicals substituted by carbon atoms having three bonds to hetero atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/28—Radicals substituted by nitrogen atoms
IE1346/70A 1969-10-29 1970-10-19 Pharmaceutical compositions comprising amidine derivatives IE34882B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
IE1342/75A IE35578B1 (en) 1969-10-29 1970-10-19 Isothioureas
IE1341/75A IE35577B1 (en) 1969-10-29 1970-10-19 Isothioureas

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5289169 1969-10-29

Publications (2)

Publication Number Publication Date
IE34882L true IE34882L (en) 1971-04-29
IE34882B1 IE34882B1 (en) 1975-09-17

Family

ID=10465723

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1346/70A IE34882B1 (en) 1969-10-29 1970-10-19 Pharmaceutical compositions comprising amidine derivatives

Country Status (11)

Country Link
JP (1) JPS4946307B1 (en)
DK (1) DK140938B (en)
ES (2) ES385015A1 (en)
FI (1) FI56001C (en)
IE (1) IE34882B1 (en)
IL (1) IL35518A (en)
NO (1) NO133197C (en)
PH (1) PH10563A (en)
SE (1) SE376613B (en)
SU (2) SU419026A3 (en)
ZA (1) ZA707151B (en)

Also Published As

Publication number Publication date
IE34882B1 (en) 1975-09-17
IL35518A0 (en) 1970-12-24
JPS4946307B1 (en) 1974-12-09
ES385015A1 (en) 1973-03-16
FI56001B (en) 1979-07-31
SU419026A3 (en) 1974-03-05
SE376613B (en) 1975-06-02
ES387088A1 (en) 1973-06-16
PH10563A (en) 1977-06-28
NO133197B (en) 1975-12-15
SU393828A3 (en) 1973-08-10
NO133197C (en) 1976-03-24
ZA707151B (en) 1971-07-28
FI56001C (en) 1979-11-12
DK140938B (en) 1979-12-10
IL35518A (en) 1978-07-31
DK140938C (en) 1980-05-19

Similar Documents

Publication Publication Date Title
ZA713539B (en) Pharmaceutical compositions
IE34966L (en) Pharmaceutical composition containing substitiuted¹biguanides
ZA717083B (en) New pharmaceutical compositions
MY7700200A (en) Pharmaceutical compositions
ZA702381B (en) Shampoo composition
CA930306A (en) Pharmaceutical compositions
ZA713877B (en) Pharmaceutical composition
ZA715832B (en) Pharmaceutical compositions
IE36108B1 (en) Pharmaceutical compositions
CY845A (en) Antiineectious pharmaceutical compositions
CA930305A (en) Pharmaceutical compositions
AU1048070A (en) Pharmaceutical composition
ZA704998B (en) Pharmaceutical compositions
ZA697733B (en) Pharmaceutical compositions
ZA716461B (en) Pharmaceutical compositions
ZA708508B (en) Therapeutic compositions
ZA695903B (en) Pharmaceutical compositions
IE34882L (en) Pharmaceutical composition
IL33808A0 (en) Pharmaceutical composition comprising phenylbutazon
IL32179A0 (en) Ulcer-inhibitory pharmaceutical compositions
CA830474A (en) Pharmaceutical composition
AU439713B2 (en) Pharmaceutical compositions
AU435541B2 (en) Pharmaceutical compositions
CA807196A (en) Pharmaceutical compositions
AU442181B2 (en) Pharmaceutical compositions